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Abstract There have been many animal studies on the
effects of organophosphorus pesticide (OP) poisoning on
thermoregulation with inconsistent results. There have
been no prospective human studies. Our aim was to
document the changes in body temperature with OP
poisoning. A prospective study was conducted in a rural
hospital in Polonnaruwa, Sri Lanka. We collected data on
sequential patients with OP poisoning and analyzed 12
patients selected from 53 presentations who had overt
signs and symptoms of OP poisoning and who had not
received atropine prior to arrival. All patients subse-
quently received specific management with atropine and/
or pralidoxime and general supportive care. Tympanic
temperature, ambient temperature, heart rate, and clinical
examination and interventions were recorded prospec-
tively throughout their hospitalization. Initial hypother-
mia as low as 32°C was observed in untreated patients.
Tympanic temperature increased over time from an early
hypothermia (<35°C in 6/12 patients) to later fever (7/12
patients >38°C at some later point). While some of the
late high temperatures occurred in the setting of marked
tachycardia, it was also apparent that in some cases fever
was not accompanied by tachycardia, making excessive
atropine or severe infection an unlikely explanation for
all the fevers. In humans, OP poisoning causes an initial
hypothermia, and this is followed by a period of normal
to high body temperature. Atropine and respiratory
complications may contribute to fever but do not account
for all cases.
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Organophosphorus pesticide (OP) self-poisoning is a
significant cause of morbidity and mortality in the
developing world [1–3], with the in-hospital case fatality
usually reported to be between 10% and 20% [1]. OPs are
acetylcholinesterase (AChE) inhibitors, thereby inhibiting
the metabolism of acetylcholine (ACh). The rapid accumu-
lation of ACh in the synaptic junctions of central nervous
system and peripheral tissues results in a “cholinergic
crisis,” characterized by receptor overstimulation and a
range of muscarinic, nicotinic, and central effects [4]. The
mainstay of treatment involves atropine, a central and
peripheral muscarinic receptor antagonist, and pralidoxime
chloride, which reactivates inhibited AChE [5].
However, the understanding of the pathophysiology of
OP poisoning is incomplete in many respects. OPs have
been reported to interfere with the control of ACh-regulated
homeostatic mechanisms such as temperature regulation
[6]. The current data on cholinergic influences on temper-
ature regulation are largely derived from animal studies.
Reports of direct CNS administration of cholinergic
agonists in the region of the hypothalamus or cerebral
ventricles of laboratory rodents resulting in hypothermia are
in contrast with other studies reporting just the opposite,
that is, heat production and/or conservation [6, 7]. This may
be related to dose; generally higher doses were associated
with hypothermia, and hyperthermia was only seen with
lower doses [6]. Other studies have demonstrated that OP
poisoning results in a period of hypothermia followed by a
fever of delayed onset [8–11], without exhibiting any of the
other classical signs of bacterial or viral infection. Further
complicating the literature, hot and cold environments have
been found to modify the sensitivity of rats and primates to
AChE inhibitors and also hypothermic and hyperthermic
responses in animals [6, 12].
It is not clear whether these observations apply to acute
human poisoning. Review of the literature regarding human
responses to OP poisoning appears to suggest that an
elevation in body temperature is a frequent outcome, but
cases are complicated by concurrent illnesses (in particular
aspiration pneumonitis/pneumonia) and interventions that
may of themselves produce high temperatures, in particular
anticholinergic agents [13–16]. In these cases, it is unclear
whether atropine was responsible for the temperature or
whether high doses of atropine were given to patients with
severe OP poisoning, and fever was a manifestation of
severe OP poisoning. Most reports of human cases with
fever following OP ingestion come from the warmer
regions of the world, such as South Asia [1–3, 17, 18],
the Middle East [13], and Africa [19]. Therefore, reported
fever in patients with OP poisoning may represent a loss of
normal thermoregulation.
The human data on OP poisoning are from case studies
based on records of routinely recorded vital signs. The aim
of this study was to prospectively and closely observe a
series of patients admitted to a regional hospital in Sri
Lanka with acute OP poisoning and document the changes
in their body temperature throughout the length of their
hospital stay.
Methods
A prospective study into the effects of OP poisoning on
tympanic temperature (as an indicator of core body temper-
ature) was undertaken at Polonnaruwa General Hospital
(PGH) in the agricultural region of North Central Sri Lanka.
It formed part of an established study into the management
of acute self-poisoning approved by the Colombo Faculty
of Medicine Ethics Committee, the Oxfordshire Clinical
Research Ethics Committee, and the Australian National
University HREC Protocol 2003/227.
All patients admitted directly or transferred to PGH with
a history of self-poisoning with an OP pesticide were
included in an initial study period of 20 days. It became
apparent during this time that treatment received in the
initial resuscitation may be having a marked effect on the
recorded temperature. Therefore, a further study period of
98 days followed, in which patients with a history of OP
poisoning were only included if they had overt signs and
symptoms of OP poisoning and yet had not received
atropine prior to arrival at PGH. We present data from both
periods only on those that presented meeting these criteria.
Each patient was seen on admission, and data were
recorded prospectively. The poison ingested was identified
from the patients’ or relatives’ histories, the bottle brought
with the patient, or the doctor’s comments in transfer
letters. Consent was gained from all study participants.
Tympanic temperature was measured as frequently as was
possible (without interfering with medical care) during the
first 6 h of admission and approximately 3-hourly thereaf-
ter. All temperatures were taken with the same Braun
ThermoScan digital ear thermometer, and medical staff
received basic training in the technique required for best
accuracy [20]. The ambient temperature was recorded
simultaneously with a mercury thermometer. Other relevant
clinical information including symptoms and signs of
poisoning and antidote administration were recorded, with
further management and patient progress details obtained
from a review of patient notes. Most patients were managed
on open wards, which are not air-conditioned and have few
fans. The ambient temperature typically varied somewhere
between 24°C and 35°C on these wards. Some patients
were managed in PGH intensive care which is air-
conditioned to a temperature of around 25°C.
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management protocol [21]. All patients received specific
management with titrated doses of atropine and/or
pralidoxime chloride (1 g 6-hourly for around 48 h), and
all patients received ongoing general supportive care.
Body temperature, ambient temperature, and heart rate
were initially plotted against time using GraphPad Prism
[version 3.02 for Windows (GraphPad Software, San Diego,
CA, USA, www.graphpad.com)]. Significant clinical notes,
the time of the first temperature measurements, and the
normal range for core body temperature (as defined by
Vassallo and Delaney 1998 [22]) were added at the
corresponding points on the graphs.
Where possible, admission plasma samples were taken
for butyrylcholinesterase activity (to show exposure) and
pesticide concentration. Plasma was separated and frozen at
−20°C until analysis. All analyses were done at Peter Eyer’s
laboratory in Munich, Germany. Butyrylcholinesterase activ-
ity was assessed as described previously [23]. Concentrations
of organophosphorus pesticides in plasma were quantified by
reversed-phase high-performance liquid chromatography and
ultraviolet detection. The lower limits of quantitation were
1 µmol/l plasma for dimethoate and 0.1 µmol/l plasma for
chlorpyrifos and quinalphos.
Results
Over the two study periods, 53 patients were admitted to
PGH with deliberate OP self- poisoning. Of these patients,
41 were excluded because they were initially asymptomatic
(17) or had received atropine therapy prior to admission
(24). There were 11 male patients and one female patient,
with a mean age of 37.9 years (range 17–65), and they had
ingested a range of OP (Table 1). All 12 patients
demonstrated manifestations of OP activity at muscarinic
and/or nicotinic receptors and had presented within 6 h of
ingestion. Five patients had a reduced level of conscious-
ness on admission. Seven required intubation and admis-
sion to the intensive care unit (ICU). One of these seven
whose admission was complicated by aspiration pneumonia
died unexpectedly 8 days after admission, although he had
been apparently stable following extubation the preceding
day.
To demonstrate the data collected, Fig. 1 shows the
temperature readings for the patient with the greatest
disturbance of temperature. This was a 43-year-old male
admitted three and a half hours after ingestion of unknown
quantities of chlorpyrifos and alcohol. He received only IV
saline prior to transfer and on arrival had a Glasgow Coma
Scale (GCS) of 4/15, pinpoint pupils (1 mm), vomiting, and
diarrhea, was diaphoretic, and had bilateral lung crepita-
tions. Pulse was 72 bpm and BP 140/80. The patient was
immediately intubated and given a total of 4 mg atropine in
bolus doses. An atropine infusion of 1.2 mg/h was
commenced 1 h later and continued for approximately
6 h. Seven hours after admission, the patient was
transferred to the ICU where he was paralyzed and sedated
with atracurium and morphine, respectively, and given
pralidoxime chloride 1 g q6h. He remained in a similar state
for the following 3 days, after which no more data were
recorded. The patient was later discharged.
The figure demonstrates severe hypothermia (32.2°C) on
admission, coinciding with classical signs of OP poisoning.
A rise in tympanic temperature was observed to follow
administration of atropine and hypothermia resolved by
12 h postingestion (Fig. 1). Thereafter, in the relatively
stable temperature of the ICU, the patient’s temperature
remained within the normal range, except for the final
measurement, which was slightly below normal.
The tympanic temperatures and heart rates of individual
patients with respect to time post-OP ingestion are shown in
Fig. 2. The same pattern is seen when the two patients with
normal butyrylcholinesterase activity are removed (data not
shown). A trend of tympanic temperature increasing from
an early hypothermia to later mild fever is demonstrated.
While some of the late high temperatures occurred in the
setting of marked tachycardia, it is also apparent that in
some cases fever was not accompanied by tachycardia,
making excessive atropine an unlikely explanation for all
the fevers. There was no visual relationship observed
between ambient and core temperature in any of these
patients nor was there an apparent relationship between
initial temperature and ambient temperature (data not
shown).
Discussion
This study was the first attempt to systematically and
prospectively record the tympanic temperatures of patients
admitted to hospital with acute OP self-poisoning. We have
confirmed that alterations in body temperature and thermo-
regulation are common in symptomatic OP poisoning, but
there is a great deal of variation largely due to treatment and
complications. We have identified a clear pattern of early
hypothermia in significant poisoning which corrects with
initial treatment with somewhat variable and smaller effects
thereafter that are less easily attributed to specific factors
frequently leading to above normal temperatures a few days
later.
These results contrast those of numerous animal studies
purporting purely hypothermic or hyperthermic responses
to OP and those that suggest that there is a significant
correlation between OP exposure and hypersensitivity to
ambient temperatures [12, 24]. The data from this study
J. Med. Toxicol. (2010) 6:379–385 381suggest that, in humans receiving antidotes, an initial
hypothermic response is followed by a delayed fever. This
relationship has been suggested in a small number of
animal studies [8–11].
On the graphs, hypothermia is shown as a lowering of
the tympanic body temperature to less than or equal to
35°C, based on generally accepted values in clinical
medicine [22]. However, it has been noted that core
Fig. 1 Heart rate, tympanic
temperature, and ambient tem-
perature following ingestion of
OP (pt. 1447)
Table 1 Patients admitted to Polonnaruwa General Hospital with acute OP poisoning who were symptomatic and had received no prior atropine
therapy
Study number 1427 1430 1436 1447 2126 2180 2169 2161 2116 2342 2142 2196
Male ✓ ✓ ✓ ✓ ✓✓✓✓✓ ✓ ✓
Age 17 34 32 43 22 32 40 50 59 26 35 65
OP ingested CP CP UO CP QP QP DZ DM DM DM/CP DM DM
Ethanol coingestion ✓✓✓
GCS on arrival (out of 15) 15 15 14 4 15 15 15 15 3 7 4 15
Time to admission (h) 3 0.5 5.5 3.5 6 3 4.5 3 3 1 4 1
Admission temperature 36.2 35.9 35.3 32.2 34.3 36.0 37.4 35.7 35.4 37.2 36.4 36.8
Time to lowest temperature (h) 11.2 1.5 5.6 3.7 4.4 10.7 18 5.4 10.6 2.0 4.7 6.2
Lowest recorded temperature 35.4 35.1 35.1 32.2 34.0 35.9 36.9 34.5 34.8 34.7 36.4 34.7
Time to highest temperature (h) 51 48 24 17.3 12.4 158 6.8 380 116 65 177 48
Highest recorded temperature 37.1 37.9 37.0 37.5 38.0 38.6 38.2 39.7 39.4 37.3 38.8 38.5
Admission BChE 251 50 NC 22 10 3,338 3,989 1,481 1,431 10 60 2,067
OP concentration (μM) 0.29 4.3 NC NA 4.68 NA NA 323 66 25/1.2 8 432
ICU admission/intubation ✓ ✓ ✓✓✓✓ ✓
Outcome D/C D/C D/C D/C D/C D/C D/C D/C RIP D/C D/C D/C
D/C discharged, CP chlorpyrifos, RIP deceased, DM dimethoate, QP Quinalphos, DZ Diazinon, UO unknown organophosphate, BChE
butyrylcholinesterase activity (normal range 3,200–5,200 mU/ml [23]), NC not collected, NA not analyzed
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triggering behavioral and autonomic cold defenses, sug-
gesting that physiological hypothermia would be closer to
36°C [25]. Using this cutoff, six of the 12 patients had
hypothermia on admission and 11 within the first 12 h.
While most publications describe fluctuations in body
temperature noticed retrospectively from examination of
patient notes, we attempted to record temperatures prospec-
tively at very frequent intervals while recording other
factors that might influence temperature. However, there
were still several limitations to the accurate determination
of the impact of OP poisoning on thermoregulation in
humans. The most important is the need to treat patients
with antidotes that also may affect temperature regulation.
Moreover, the treatment is individualized to each patient
Fig. 2 The tympanic temper-
atures and heart rates of indi-
vidual subjects in Table 1
against time since OP ingestion,
from admission until discharge
from hospital. Note that temper-
atures are consistently low–
normal early and become
normal or high after 24–48 h,
while heart rate is evenly
scattered and shows little change
over time, indicating atropine
therapy and infection (which
would both cause tachycardia as
well as a temperature rise) are
not likely to be responsible for
the trends. Two patients (x+)
appear to have much less severe
poisoning as BChE was not
depressed. Hyperbolic equation
for other ten: Temp ¼ 35:4 þ
2:8   hours= hours þ 25 ðÞ
Table 2 Clinical notes coinciding with a rise in body temperature in
patients with OP poisoning at PGH
Drug administration
Atropine (most common factor)
Chlorpromazine
Diazepam
Carbamazepine
Benzhexol
Signs of alcohol withdrawal
Use of physical restraint
Lower respiratory tract infection
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aggressive, or were developing a respiratory tract infection.
Table 2 lists some of the many factors known to alter
thermoregulation that we noted in the first 20 days may
have influenced patient temperatures in this study. It
would have been useful to have more facilities to exclude
infection in those with late onset of fevers. Body temper-
atures may also have been influenced by a patient’s
location. That is, whether they were near an electric fan,
in the center of an overcrowded ward, or whether they
were in the more controlled environment of the intensive
care unit. However, ambient temperature did not seem to
have an obvious relationship with tympanic temperature in
most patients.
Another unavoidable limitation was the timing of the
start for recording thermometry. While one patient
presented to PGH 30 min after OP ingestion, another
was admitted 6 h postingestion. Finally, the patients in
this study may not be representative of all patients
presenting with OP poisoning. Although the number of
patients included in this study was small, there was only
one death due to OP poisoning, which is less than the
estimated 15% to 20% mortality rate for symptomatic OP
poisoning [1]. The doses of poison ingested are unknown,
meaning data analysis from a dose–response perspective is
impossible.
It is possible that the temperature aberration in some
patients was due to alcohol, although the three patients
with known ingestion of ethanol were not clearly
different from the rest (Table 1). Effects of ethanol in
humans at the ambient temperatures in Sri Lanka have
been neither consistent nor significant [26]. It is also
possible (but unlikely) that effects on temperature in OP
poisoning patients are due to solvents rather than the
OP.
Future studies may be able to explore the mechanism
for heat dissipation in early organophosphorus poison-
ing, for example by measuring skin blood flow and
temperature and the differences between core and
peripheral temperature. Such studies might also address
the issue of whether hyperthermia contributes to later
elevated temperatures. More studies could also be done
exploring the medium to long-term effects on thermo-
regulation after the acute poisoning period. OP are well
known to produce long-lasting effects in humans in the
form of an intermediate syndrome (impaired neuromus-
cular transmission 24 to 96 h after exposure) and
delayed polyneuropathy, which may develop days to
weeks after the exposure [4]. Regular temperature
measurement in patients experiencing these delayed sets
of symptoms may also show a pattern of temperature
changes that might be attributed to the action of OP on
thermoregulation.
Conclusions
This study has allowed a generalization to be made that, in
humans, OP poisoning causes an initial fall in body
temperature, and this is followed by a period of normal to
high body temperature, as measured by tympanic thermom-
etry. Of the many possible confounders, it is the life-saving
medical interventions received by each patient and frequent
respiratory complications that are the greatest hindrances to
the accurate observation of trends in body temperature
during the period of intensive management following
admission to hospital. Thus, the level of experimental
control required for a more conclusive answer on the direct
acute effects of OP poisoning in humans is unattainable.
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